Skip to content

Meal Timing and Blood Pressure

The Impact of Meal Timing on Neurovascular Control in Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04133701
Enrollment
34
Registered
2019-10-21
Start date
2022-02-02
Completion date
2022-12-16
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Neurovascular Control

Keywords

Meal Timing, Blood Pressure, Time-Restricted Feeding, Sympathetic Nerve Activity

Brief summary

Brain blood flow, blood pressure, and neurovascular control mechanisms will be measured in middle-aged adults before and after a brief intervention period. The intervention will consist of changing the time in which the participant consumes food each day.

Detailed description

Healthy adults experience a 10-20% decrease in night-time blood pressure, compared with day-time blood pressure. However, 20-40% of middle-aged adults do not demonstrate a decrease in blood pressure. Abnormal blood pressure patterns are linked to sleep disturbances, hypertension, and associated with elevated cardiovascular risk and mortality. Additionally, abnormal diurnal blood pressure patterns are associated with impaired neurovascular control of the circulation, contributing to an increased risk of hypertension, stroke, and cardiovascular disease. Importantly, midlife is the critical period for implementing interventions to prevent or delay future cardiovascular disease. Recent data demonstrates that time-restricted feeding may normalize blood pressure patterns. The overall goal of this study is to determine if time-restricted feeding normalizes blood pressure patterns and improves neurovascular control. The research aims are: 1. To determine the effect of meal timing on blood pressure patterns in middle-aged adults. 2. To determine the effect of meal timing on neurovascular control in middle-aged adults.

Interventions

After baseline measurements have been completed, participants will enroll in a time-restricted feeding intervention. Participants will be asked to restrict the time in which they eat each day to 10 hours, fasting for the remaining 14 hours. Participants will also be asked to finish their last meal of the day at least 2 hours prior to bedtime.

Sponsors

American Heart Association
CollaboratorOTHER
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

The interventional study model used will consist of a time-restricted feeding intervention.

Eligibility

Sex/Gender
ALL
Age
50 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI ≤ 34 kg/m2 * Non-smoking * Sedentary or recreationally active * ≤ 2 Alcoholic drinks per day * Female subjects: Perimenopausal/Postmenopausal

Exclusion criteria

* History or evidence of hepatic, renal, hematological, peripheral vascular disease, or stroke/neurovascular disease, diabetes, uncontrolled hypertension, sleep apnea * On medications used to treat/manage diseases listed above * Work overnight shifts * Clinically diagnosed anxiety or depression * Pregnant or trying to become pregnant * Significant surgical history * Other significant medical conditions at investigator's discretion

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure measured continuously over a period of 24 hourContinuously over a 24-hour periodUtilize an ambulatory blood pressure monitor to measure blood pressure values continuously over a 24-hour period.
Neurovascular Control: Change in the brain blood flowBaseline and 5 weeksChange in brain blood flow will be measured using a transcranial Doppler ultrasound in response to a breathing test.
Neurovascular Control: Change in the blood pressureBaseline and 5 weeksChange in blood pressure in response to a breathing test.
Neurovascular Control: change in the sympathetic nerve activityBaseline and 5 weeksChange in sympathetic nerve activity will be measured using microneurography in response to a breathing test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026